Treatment of Retinal Vein Occlusion (RVO) With Open-Label Anecortave Acetate (15mg.)

NCT00211354 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No subjects enrolled

Conditions

Retinal Vein Occlusion

Interventions

DRUG: Anecortave Acetate

Sponsor

Manhattan Eye, Ear & Throat Hospital

Collaborators

[object Object]